1-4 of 4
Jared Bearss
Close
Sort by
Journal Articles

HT-6184 Inhibits the Formation of the NLRP3 Inflammasome in Human Monocytic THP-1 Cells

Benjamin Bearss, Devan Bursey, Taylor Avei, Alexis Mollard, Jared Bearss, Margit Maria Janat-Amsbury, David J. Bearss
Journal: Blood
Blood (2023) 142 (Supplement 1): 3916.
https://doi.org/10.1182/blood-2023-182060
Published: 2023
Journal Articles

Modulation of NLRP3 Inflammasome in Monocytes By HT-6184 in a Single-Cell Proteomic Study

Devan Bursey, Benjamin Bearss, Taylor Avei, Alexis Mollard, Jared Bearss, Margit Maria Janat-Amsbury, David J. Bearss
Journal: Blood
Blood (2023) 142 (Supplement 1): 1170.
https://doi.org/10.1182/blood-2023-182210
Published: 2023
Journal Articles

Ex-Vivo Human Whole Blood Assay for Evaluating the Pharmacodynamics of HT-6184: Reduction in NLRP3 Inflammasome Mediated Cytokine Production

Taylor Avei, Devan Bursey, Benjamin Bearss, Alexis Mollard, Jared Bearss, Margit Maria Janat-Amsbury, David J. Bearss
Journal: Blood
Blood (2023) 142 (Supplement 1): 5345.
https://doi.org/10.1182/blood-2023-182231
Published: 2023
Journal Articles

Preclinical Characterization of the JAK-2 Inhibitor, SGI-1252

Kausar Begam Riaz Ahmed, Roberto H Nussenzveig, PhD, Andrew T. Chen, DO, Josef T. Prchal, MD, Charles J. Parker, MD, Eric Gourley, Paul Severson, Jared Bearss, Carissa Jones, Steven L. Warner, David Vollmer, David J. Bearss
Journal: Blood
Blood (2008) 112 (11): 2629.
https://doi.org/10.1182/blood.V112.11.2629.2629
Published: 2008